LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

Home・Akciju saraksts・Smith & Nephew PLC ADR

Smith & Nephew PLC ADR

Slēgts

32.99 -2.94

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

32.9

Max

34.01

Galvenie mērījumi
By Trading Economics
Ienākumi	35M 331M
Pārdošana	203M 3.2B
P/E Sektora vidējais	23.832 61.417
Dividenžu ienesīgums	2.29
Peļņas marža	10.368
Darbinieki	17,000
EBITDA	133M 856M

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+1.89% upside

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	2.29% 2.40%

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-712M 14B
Iepriekšējā atvēršanas cena	35.93
Iepriekšējā slēgšanas cena	32.99

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

26.64 / 28.37 Atbalsts un pretestība

Smith & Nephew PLC ADR Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 10. marts 20:38 UTC

Peļņas

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

2026. g. 10. marts 23:57 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 10. marts 23:57 UTC

Tirgus saruna

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

2026. g. 10. marts 23:47 UTC

Tirgus saruna

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

2026. g. 10. marts 23:37 UTC

Iegādes, apvienošanās, pārņemšana

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

2026. g. 10. marts 23:37 UTC

Iegādes, apvienošanās, pārņemšana

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

2026. g. 10. marts 23:37 UTC

Iegādes, apvienošanās, pārņemšana

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

2026. g. 10. marts 23:37 UTC

Iegādes, apvienošanās, pārņemšana

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

2026. g. 10. marts 23:35 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

2026. g. 10. marts 23:06 UTC

Peļņas

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

2026. g. 10. marts 22:51 UTC

Galvenie ziņu notikumi

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

2026. g. 10. marts 21:39 UTC

Iegādes, apvienošanās, pārņemšana

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

2026. g. 10. marts 21:21 UTC

Peļņas

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

2026. g. 10. marts 21:15 UTC

Peļņas

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

2026. g. 10. marts 21:15 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

2026. g. 10. marts 21:14 UTC

Peļņas

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

2026. g. 10. marts 21:13 UTC

Peļņas

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

2026. g. 10. marts 21:12 UTC

Peļņas

Franco-Nevada 4Q Rev $597.3M >FNV

2026. g. 10. marts 21:12 UTC

Peļņas

Franco-Nevada 4Q EPS $1.90

2026. g. 10. marts 20:57 UTC

Peļņas

Oracle Stock Jumps on Earnings Beat -- Barrons.com

2026. g. 10. marts 20:50 UTC

Tirgus saruna

Peļņas

Tech, Media & Telecom Roundup: Market Talk

2026. g. 10. marts 20:44 UTC

Peļņas

Oracle Stock Jumps on Earnings Beat -- Barrons.com

2026. g. 10. marts 20:34 UTC

Tirgus saruna

Peļņas

Global Equities Roundup: Market Talk

2026. g. 10. marts 20:34 UTC

Tirgus saruna

Peļņas

Oracle Building More Software for Less Money After Restructuring -- Market Talk

2026. g. 10. marts 20:23 UTC

Peļņas

Oracle Stock Jumps on Earnings Beat -- Barrons.com

2026. g. 10. marts 20:16 UTC

Peļņas

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

2026. g. 10. marts 20:14 UTC

Peļņas

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

2026. g. 10. marts 20:14 UTC

Peļņas

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

2026. g. 10. marts 20:13 UTC

Peļņas

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

2026. g. 10. marts 20:12 UTC

Peļņas

Oracle Stock Jumps on Earnings Beat -- Barrons.com

Salīdzinājums

Cenas izmaiņa

Smith & Nephew PLC ADR Prognoze

Cenas mērķis

By TipRanks

1.89% augšup

Prognoze 12 mēnešiem

Vidējais 34.96 USD 1.89%

Augstākais 35 USD

Zemākais 34.91 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Smith & Nephew PLC ADR — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

2 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 2 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Smith & Nephew PLC ADR — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

26.64 / 28.37Atbalsts un pretestība

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.